drugset / Trial / NCT01147692

A Drug Interaction Study of Simvastatin and Albiglutide

NCT01147692

Phase 1 Completed 40 enrolled GlaxoSmithKline
NaSingle-groupOpen-labelBasic science

Summary

This open-label study evaluates the pharmacokinetics of simvastatin when coadministered with albiglutide in healthy adult subjects. The primary objective is to assess the effect of albiglutide doses on the pharmacokinetics of simvastatin.

Timeline

Start
2010-05-19
Primary completion
2010-08-27
Completion
2010-08-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule 80 mg
Subject albiglutide Peptide Subcutaneous